EFFECT OF TENS ON ACUPOINTS IN PREMENSTRUAL SYNDROME

Cairo University50 enrolled

Overview

These will be no effect of transcutaneous electrical acupoint stimulation on premenstrual syndrome Does transcutaneous electrical acupoint stimulation affect premenstrual syndrome (PMS)?

Premenstrual syndrome is a collection of emotional, physiological, and behavioral symptoms that develop around the end of the luteal phase and fade away with or after menstruation Due to limited evidence on the efficacy of sustained progesterone and the side effects of antidepressant and anxiolytics, in some cases, alternative therapies are recommended for patients with PMS TEAS may be more effective than other forms of transcutaneous electrical nerve stimulation (TENS) in modulating brain activity because acupoint areas contain relatively denser neural and neuroactive components than non-acupoint areas TEAS has been reported to have similar efficacy as acupuncture, electrical acupuncture, and TENS

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Premenstrual Pain

Interventions

Transcutaneous electrical nerve stimulation (TENS)DEVICE

Control group will receive TEAS on sham acupoint daily from 3 days before menstruation to the 4th day of menstruation for 3 consequent menstrual cycles Study group will receive TEAS on neurogenic acupoints daily from 3 days before menstruation to the 4th day of menstruation for 3 consequent menstrual cycles

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 25 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Their age will range from 18 to 25 years. * The regularity of menstrual cycle is 28-35 days. * All of them suffering from moderate and sever PMS. * All participants are virgin. * Their BMI will range from 25-30 kg\\m2. Exclusion Criteria: * Any pathological findings in the pelvic cavity as PCO, Endometriosis and pelvic inflammatory disease. * Any history of gynecological intervention. * Have any condition impedes the use of electrotherapy. * Receiving sedatives or any medical treatment. * Having irregular menstruation.

Outcomes

Primary Outcomes

pain severity

The pain intensity will be assessed through visual analogue scale (VAS) for each participant in both groups before and after treatment Each participant will be asked to mark a point on VAS line between the extremes that related to her current pain intensity

Time frame: Up to 3 monthes

premenstrual syndrome severity

Participants can differentiate between their experiences of different symptoms during menstrual cycle and they will be assessed before and after treatment using the Menstrual Distress Questionnaire (MDQ) Each participant will be asked to rate their experience of each of the symptoms on the MDQ on a scale ranging from no experience of the symptom to an acute or partially disabling experience of the symptom

Time frame: up to 3 monthes

Central Contacts

Azza Barmoud, professor

CONTACT

01008410312 drazzakassab@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.